FREEDOM Trial’s Data Favors CABG Over PCI For Patients With Diabetes
This article was originally published in The Gray Sheet
Executive Summary
Patients in the trial showed significantly reduced rates in the composite outcome of death, heart attacks and strokes after five years with CABG versus percutaneous coronary intervention.